Abstract
Oral chronic GVHD (cGVHD) is a common, late complication of alloSCT that is associated with significant patient morbidity. The NIH Oral Mucosal Score (NIH OMS) was developed to assess oral cGVHD therapeutic response, but has not been fully validated. This study’s purpose was to conduct a rigorous construct validity and internal consistency analysis of this score and its components (erythema, lichenoid, ulcers, mucoceles) using established measures of oral pain, oral function, oral-related quality-of-life, nutrition and laboratory parameters in 198 patients with cGVHD. The construct validity of the NIH OMS was supported: a moderate correlation was observed between NIH OMS and mouth pain (rho=0.43), while a weaker correlation was observed with low albumin (rho=−0.26). Total NIH OMS, erythema and lichenoid components were associated with malnutrition, oral pain and impaired oral QOL, while ulcers were only associated with oral pain. No associations were found between mucoceles and any indicator evaluated, including salivary function or xerostomia. Kappa determined between scale components was low overall (all ⩽0.35), supporting a conclusion that each component measures a distinct manifestation of oral cGVHD. This study supports the use of the NIH OMS and its components (erythema, lichenoid and ulcerations) to measure clinician-reported severity of oral cGVHD.
Similar content being viewed by others
References
Copelan EA . Hematopoietic stem-cell transplantation. N Engl J Med 2006; 354: 1813–1826.
Baird K, Pavletic SZ . Chronic graft versus host disease. Curr Opin Hematol 2006; 13: 426–435.
Schubert MM, Correa ME . Oral graft-versus-host disease. Dent Clin North Am 2008; 52: 79–109.
Filipovich AH, Weisdorf D, Pavletic S, Socie G, Wingard JR, Lee SJ et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biol Blood Marrow Transplant 2005; 11: 945–956.
Imanguli MM, Alevizos I, Brown R, Pavletic SZ, Atkinson JC . Oral graft-versus-host disease. Oral Dis 2008; 14: 396–412.
Fassil H, Bassim C, Mays J, Edwards D, Baird K, Steinberg S et al. Oral chronic graft-vs-host disease characterization using the NIH scale. J Dent Res 2012; 91: 45S–51S.
Fall-Dickson JM, Mitchell SA, Marden S, Ramsay ES, Guadagnini JP, Wu TX et al. Oral symptom intensity, health-related quality of life, and correlative salivary cytokines in adult survivors of hematopoietic stem cell transplantation with oral chronic graft-versus-host disease. Biol Blood Marrow Transplant 2010; 16: 948–956.
Meier JK, Wolff D, Pavletic S, Greinix H, Gosau M, Bertz H et al. Oral chronic graft-versus-host disease report from the International Consensus Conference on clinical practice in cGVHD. Clin Oral Invest 2011; 15: 127–139.
Bassim C, Ambatipudi K, Mays J, Edwards D, Swatkoski S, Fassil H et al. Quantitative salivary proteomic differences in oral chronic graft-versus-host disease. J Clin Immunol 2012; 32: 1390–1399.
Treister N, Duncan C, Cutler C, Lehmann L . How we treat oral chronic graft-versus-host disease. Blood 2012; 120: 3407–3418.
Pavletic SZ, Martin P, Lee SJ, Mitchell S, Jacobsohn D, Cowen EW et al. Measuring therapeutic response in chronic graft-versus-host disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. Response Criteria Working Group report. Biol Blood Marrow Transplant 2006; 12: 252–266.
Elad S, Zadik Y, Zeevi I, Miyazaki A, de Figueiredo MA, Or R . Oral cancer in patients after hematopoietic stem-cell transplantation: long-term follow-up suggests an increased risk for recurrence. Transplantation 2010; 90: 1243–1244.
Mitchell SA, Jacobsohn D, Thormann Powers KE, Carpenter PA, Flowers ME, Cowen EW et al. A multicenter pilot evaluation of the national institutes of health chronic graft-versus-host disease (cGVHD) therapeutic response measures: feasibility, interrater reliability, and minimum detectable change. Biol Blood Marrow Transplant 2011; 17: 1619–1629.
Treister NS, Stevenson K, Kim H, Woo SB, Soiffer R, Cutler C . Oral chronic graft-versus-host disease scoring using the NIH consensus criteria. Biol Blood Marrow Transplant 2010; 16: 108–114.
Treister N, Chai X, Kurland B, Pavletic S, Weisdorf D, Pidala J et al. Measurement of oral chronic GVHD: results from the chronic GVHD Consortium. Bone Marrow Transplant 2013; 48: 1123–1128.
Lee S, Cook EF, Soiffer R, Antin JH . Development and validation of a scale to measure symptoms of chronic graft-versus-host disease. Biol Blood Marrow Transplant 2002; 8: 444–452.
Slade G, Spencer A . Development and evaluation of the Oral Health Impact Profile. Community Dent Health 1994; 11: 3–11.
McQuellon RP, Russell GB, Cella DF, Craven BL, Brady M, Bonomi A et al. Quality of life measurement in bone marrow transplantation: development of the Functional Assessment of Cancer Therapy-Bone Marrow Transplant (FACT-BMT) scale. Bone Marrow Transplant 1997; 19: 357–368.
Bauer J, Capra S, Ferguson M . Use of the scored Patient-Generated Subjective Global Assessment (PG-SGA) as a nutrition assessment tool in patients with cancer. Eur J Clin Nutr 2002; 56: 779–785.
Agresti A . Categorical Data Analysis. John Wiley and Sons, Inc.: New York, NY, 1990.
Hollander M, Wolfe D . Nonparametric Statistical Methods, Second Edition. John Wily and Sons, Inc.: New York, 1999.
Mehta C, Patel N . A network algorithm for performing Fisher’s exact test in r x c contingency tables. J Am Stat Assoc 1983; 78: 427–434.
Cohen J . Statistical power analysis for the behavioral sciences. L Erlbaum Associates: Hillsdale, NJ, 1988.
Elad S, Zeevi I, Or R, Resnick IB, Dray L, Shapira MY . Validation of the National Institutes of Health (NIH) scale for oral chronic graft-versus-host disease (cGVHD). Biol Blood Marrow Transplant 2010; 16: 62–69.
Mays J, Fassil H, Edward D, Pavletic S, Bassim C . Oral chronic graft-versus-host disease: Current pathogenesis, therapy, and research. Oral Dis 2012; 19: 327–346.
Imanguli MM, Atkinson JC, Mitchell SA, Avila DN, Bishop RJ, Cowen EW et al. Salivary gland involvement in chronic graft-versus-host disease: prevalence, clinical significance, and recommendations for evaluation. Biol Blood Marrow Transplant 2010; 16: 1362–1369.
Agha-Hosseini F, Mirzaii-Dizgah I, Ghavamzadeh L, Ghavamzadeh A, Tohidast-Acrad Z . Effect of pilocarpine hydrochloride on unstimulated whole saliva flow rate and composition in patients with chronic graft-versus-host disease (cGVHD). Bone Marrow Transplant 2007; 39: 431–434.
Gotoh S, Watanabe Y, Fujibayashi T . Validity of stimulated whole saliva collection as a sialometric evaluation for diagnosing Sjogren's syndrome. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2005; 99: 299–302.
Grkovic L, Baird K, Steinberg SM, Williams KM, Pulanic D, Cowen EW et al. Clinical laboratory markers of inflammation as determinants of chronic graft-versus-host disease activity and NIH global severity. Leukemia 2012; 26: 633–643.
Acknowledgements
H Fassil’s research year was made possible through the Clinical Research Training Program, a public-private partnership supported jointly by the NIH and Pfizer Inc., and by the Intramural Research Program of the National Cancer Institute, Center for Cancer Research, National Institute of Health.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Bassim, C., Fassil, H., Mays, J. et al. Validation of the National Institutes of Health chronic GVHD Oral Mucosal Score using component-specific measures. Bone Marrow Transplant 49, 116–121 (2014). https://doi.org/10.1038/bmt.2013.137
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/bmt.2013.137
- Springer Nature Limited
Keywords
This article is cited by
-
The effect of conditioning regimen and prescribed medications on hyposalivation in haematopoietic cell transplantation (HCT) patients: an 18-month prospective longitudinal study
Clinical Oral Investigations (2023)
-
Oral manifestations of graft-versus-host disease in patients submitted to allogeneic hematopoietic stem cell transplantation: the experience of a Brazilian Cancer Center
Supportive Care in Cancer (2022)
-
Effect of ruxolitinib on the oral mucosa of patients with steroid-refractory chronic Graft-versus-Host disease and oral involvement
Clinical Oral Investigations (2022)
-
Oral health–related quality of life of patients with oral chronic graft-versus-host disease
Supportive Care in Cancer (2021)
-
Clinical approach in the management of oral chronic graft-versus-host disease (cGVHD) in a series of specialized medical centers
Supportive Care in Cancer (2015)